calcium phosphate, dibasic, dihydrate has been researched along with Hypercalcemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capoluongo, E; De Paolis, E; Ferraro, PM; Gambaro, G; Gervasoni, J; Minucci, A; Naticchia, A; Persichilli, S; Primiano, A | 1 |
Asplin, JR; Bushinsky, DA | 1 |
2 other study(ies) available for calcium phosphate, dibasic, dihydrate and Hypercalcemia
Article | Year |
---|---|
A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.
Topics: Adult; Calcium Phosphates; Genotype; Humans; Hypercalcemia; Hypercalciuria; Kidney; Kidney Calculi; Male; Mutation; Nephrocalcinosis; Nephrolithiasis; Osteoporosis; Parathyroid Hormone; Pedigree; Recurrence; Renal Elimination; Sequence Analysis, DNA; Tomography, X-Ray Computed; Vitamin D3 24-Hydroxylase; Young Adult | 2017 |
Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Topics: Animals; Benzothiadiazines; Calcinosis; Calcium Oxalate; Calcium Phosphates; Disease Models, Animal; Diuretics; Hypercalcemia; Kidney Calculi; Linear Models; Male; Probability; Rats; Rats, Inbred Strains; Reference Values; Sensitivity and Specificity; Sodium Chloride Symporter Inhibitors; Urinalysis | 2005 |